whitepaper

Whitepaper: Biochip array technology – an effective and reliable multi-analytical tool

Posted: 1 September 2016 | | No comments yet

In this whitepaper, discover how biochip array technology can provide a platform for the simultaneous determination of multiple drug residues from a single sample…

Aim

Multiplex screening of a broad range of drug residues from a single sample over a range of matrices with a single analytical platform.

Biochip Array Technology

Biochip Array Technology (BAT) provides a platform for the simultaneous determination of multiple drug residues from a single sample using miniaturized immunoassays with implications in the reduction of sample/reagent consumption and an increase in the output of test results.1,2
The biochip: the core of the technology

The core of the system is the biochip (9mm x 9mm) and represents the platform in which the capture molecules are immobilized and stabilised in pre-defined x,y coordinates defining arrays of discrete test regions (DTRs) on a pre-activated surface (Figure 1). Up to 25 tests can be carried out per biochip. The biochip is also the vessel where simultaneous chemiluminescent immunoreactions take place. The biochips are supplied in carriers containing 3 x 3 biochips, which is equivalent to nine reaction wells per carrier, where samples and reagents are added. A carrier handling tray is provided with the system, which allows the simultaneous handling of six carriers (54 biochips).

This whitepaper is restricted to logged-in members. Login or become a member now (it's free!) to read it.


Related topics

Related organisations

Send this to a friend